- Home
- REXR vs HALO Comparison
REXR vs HALO Comparison
Compare REXR & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REXR
- HALO
- Stock Information
- Founded
- REXR 2013
- HALO 1998
- Country
- REXR United States
- HALO United States
- Employees
- REXR N/A
- HALO N/A
- Industry
- REXR Real Estate Investment Trusts
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- REXR Real Estate
- HALO Health Care
- Exchange
- REXR Nasdaq
- HALO Nasdaq
- Market Cap
- REXR 8.6B
- HALO 7.6B
- IPO Year
- REXR 2013
- HALO N/A
- Fundamental
- Price
- REXR $43.39
- HALO $76.90
- Analyst Decision
- REXR Hold
- HALO Buy
- Analyst Count
- REXR 9
- HALO 8
- Target Price
- REXR $40.22
- HALO $70.25
- AVG Volume (30 Days)
- REXR 2.8M
- HALO 2.0M
- Earning Date
- REXR 10-15-2025
- HALO 10-30-2025
- Dividend Yield
- REXR 3.94%
- HALO N/A
- EPS Growth
- REXR 11.21
- HALO 68.93
- EPS
- REXR 1.35
- HALO 4.37
- Revenue
- REXR $986,532,000.00
- HALO $1,178,672,000.00
- Revenue This Year
- REXR $9.35
- HALO $32.57
- Revenue Next Year
- REXR $6.25
- HALO $23.25
- P/E Ratio
- REXR $32.40
- HALO $17.65
- Revenue Growth
- REXR 13.72
- HALO 34.97
- 52 Week Low
- REXR $29.68
- HALO $42.01
- 52 Week High
- REXR $52.37
- HALO $77.60
- Technical
- Relative Strength Index (RSI)
- REXR 70.38
- HALO 77.94
- Support Level
- REXR $42.50
- HALO $74.52
- Resistance Level
- REXR $42.65
- HALO $76.28
- Average True Range (ATR)
- REXR 0.81
- HALO 1.63
- MACD
- REXR 0.16
- HALO -0.06
- Stochastic Oscillator
- REXR 89.77
- HALO 88.60
About REXR Rexford Industrial Realty Inc.
Rexford Industrial Realty Inc is a real estate investment trust engaged in owning, operating, and acquiring industrial properties in Southern California infill markets. The goal is to generate attractive risk-adjusted returns for stockholders by providing superior access to industrial property investments in Southern California infill markets. It has one operating segment business of investing in, operating, and repositioning/redeveloping industrial real estate properties located in Southern California infill markets.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.